← Leaderboards
Masahiro Hitomi
Cleveland Clinic Lerner Com-Cwru
$586,325
Attributed
$586,325
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $235.5K · FY2010–18$250K$187.5K$125K$62.5K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$586,325 · 2
By mechanism
R21$427,825 · 1
R03$158,500 · 1
Top collaborators
No co-investigators on record.
Most similar at Cleveland Clinic Lerner Com-Cwru
Same institution · by research overlap
- Hisashi Tanaka$4,123,912
- Jae U Jung$74,270,295
- Micheala A Aldred$9,408,014
Others in their field
Top investigators on “Signal Transduction”
- Peter B. Gilbert · Fred Hutchinson Cancer Center$148,539,615
- David Heimbrook · Leidos Biomedical Research, Inc.$82,049,940
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$70,290,471
- Garret A Fitzgerald · University Of Pennsylvania$66,142,222
- Michael Barry Kastan · Duke University$64,512,357
- Randall J Bateman · Washington University$62,939,456
Research focus
Signal TransductionCell CyclePlayBiologicalBaseCellsMalignant NeoplasmsPathway InteractionsStem CellsTumorPreventMolecularAlzheimer&AposAtm GeneDisease-Causing MutationBrainAtaxia Telangiectasia Mutated ProteinDesignDna DamageAgingChromosomal BreaksCell DeathBiologyCell Cycle Regulation
Grant awards (4)
Asymmetric cell division drives therapeutic resistance and self-renewal in glioblastoma$79,250
R03 · FY2018 · CA · contact PI
Asymmetric cell division drives therapeutic resistance and self-renewal in glioblastoma$79,250
R03 · FY2017 · CA · contact PI
ATM (Ataxia Telangiectasia Mutated) signaling through cyclin D1$192,325
R21 · FY2011 · NS · contact PI
ATM (Ataxia Telangiectasia Mutated) signaling through cyclin D1$235,500
R21 · FY2010 · NS · contact PI